← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 18, 2022Last known activity
Feb 10, 2025
Timeline
2010s
- Jan 1, 2019
Immorna Biotherapeutics, Inc.— Founded
Drugs by trial phase (5 distinct, 7 trials)
Phase 2 (3 own, 0 via acquisition)
Recent trials (7)
- NCT06781125Lead sponsorPhase 1Feb 10, 2025
- NCT06564194Lead sponsorPhase 1Sep 25, 2024
- NCT06581575Lead sponsorPhase 2Sep 20, 2024
- NCT05871541Lead sponsorPhase 1May 26, 2023
- NCT05743335Lead sponsorPhase 1/Phase 2Mar 20, 2023
- NCT05727839Lead sponsorPhase 1Feb 24, 2023
- NCT05539157Lead sponsorPhase 1Oct 18, 2022
Details
- Founded
- Hangzhou, CN Jan 1, 2019
- Last known activity
- Feb 10, 2025